FDA Makes Breaking Announcement on Contentious Booster Shot

A federal advisory panel said Friday the Food and Drug Administration (FDA) should not approve a third booster dose of Pfizer and BioNTech’s COVID-19 vaccine for everyone 16 or older, but indicated they would be open to boosters for older people.

The panel voted overwhelmingly against the recommendation, 16 to 2.

Friday’s vote from the FDA’s vaccine advisory committee deals a major blow to the Biden administration’s plan to administer booster doses beginning Sept. 20.

The increasingly contentious issue of boosters has divided outside scientists as well as some inside the FDA.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Send this to a friend